HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Activity Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davies, J. R. Articles by Weissberg, P. L. Search for Related Content PubMed PubMed Citation Articles by Davies, J. R. Articles by Weissberg, P. L.

Molecular and Metabolic Imaging of Atherosclerosis^*

School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom

Atherosclerosis is a systemic disease that affects most major arteries of the body and is the most common cause of premature death in the western world. It develops slowly and often asymptomatically, so that for many patients its first manifestation is sudden cardiac death, stroke, or myocardial infarction. The current gold standard for imaging atherosclerosis is x-ray angiography. However, recent advances in understanding of the pathobiology of atherosclerosis have highlighted the inadequacies of this technique and the need for better imaging approaches. The purpose of this article is to briefly outline the biology of atherosclerosis and to review the techniques available to image it, concentrating specifically on those that detect metabolic or inflammatory changes within the atherosclerotic plaque.

Key Words: atherosclerosis • nuclear medicine • PET • radionuclide • thrombus

Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  

This article has been cited by other articles:

				S. Ishino, T. Mukai, Y. Kuge, N. Kume, M. Ogawa, N. Takai, J. Kamihashi, M. Shiomi, M. Minami, T. Kita, et al. Targeting of Lectinlike Oxidized Low-Density Lipoprotein Receptor 1 (LOX-1) with 99mTc-Labeled Anti-LOX-1 Antibody: Potential Agent for Imaging of Vulnerable Plaque J. Nucl. Med., October 1, 2008; 49(10): 1677 - 1685. [Abstract] [Full Text] [PDF]

				G. A. Beller Noninvasive Screening for Coronary Atherosclerosis and Silent Ischemia in Asymptomatic Type 2 Diabetic Patients: Is it Appropriate and Cost-Effective? J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1918 - 1923. [Abstract] [Full Text] [PDF]

				C. P. Derdeyn Carotid Stenting for Asymptomatic Carotid Stenosis: Trial It Stroke, February 1, 2007; 38(2): 715 - 720. [Abstract] [Full Text] [PDF]

				S. de Voogd, R. C. W. Wolfs, N. M. Jansonius, J. C. M. Witteman, A. Hofman, and P. T. V. M. de Jong Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: the rotterdam study. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3772 - 3776. [Abstract] [Full Text] [PDF]

				F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF]

				T. Funk, D. L. Kirch, J. E. Koss, E. Botvinick, and B. H. Hasegawa A Novel Approach to Multipinhole SPECT for Myocardial Perfusion Imaging J. Nucl. Med., April 1, 2006; 47(4): 595 - 602. [Abstract] [Full Text] [PDF]

				P J Ell The contribution of PET/CT to improved patient management Br. J. Radiol., January 1, 2006; 79(937): 32 - 36. [Abstract] [Full Text] [PDF]